185 related articles for article (PubMed ID: 27862691)
1. Evaluation of the use of global haemostasis assays to monitor treatment in factor XI deficiency.
Pike GN; Cumming AM; Thachil J; Hay CR; Burthem J; Bolton-Maggs PH
Haemophilia; 2017 Mar; 23(2):273-283. PubMed ID: 27862691
[TBL] [Abstract][Full Text] [Related]
2. In vitro comparison of the effect of two factor XI (FXI) concentrates on thrombin generation in major FXI deficiency.
Pike GN; Cumming AM; Hay CR; Sempasa B; Sutherland M; Thachil J; Burthem J; Bolton-Maggs PH
Haemophilia; 2016 May; 22(3):403-10. PubMed ID: 26558335
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the use of rotational thromboelastometry in the assessment of FXI deficency.
Pike GN; Cumming AM; Thachil J; Hay CRM; Bolton-Maggs PHB; Burthem J
Haemophilia; 2017 May; 23(3):449-457. PubMed ID: 28092924
[TBL] [Abstract][Full Text] [Related]
4. The impact of thrombin generation and rotation thromboelastometry on assessment of severity of factor XI deficiency.
Livnat T; Shenkman B; Martinowitz U; Zivelin A; Dardik R; Tamarin I; Mansharov R; Budnik I; Salomon O
Thromb Res; 2015 Aug; 136(2):465-73. PubMed ID: 26160656
[TBL] [Abstract][Full Text] [Related]
5. Management of factor XI deficiency in oncological liver and colorectal surgery by therapeutic plasma exchange: A case report.
Burgos Pratx LD; Santoro DM; Mileo FG; Martinuzzo ME; Ardiles V; de Santibañes E; Salamone HJ
Transfus Apher Sci; 2021 Oct; 60(5):103176. PubMed ID: 34127376
[TBL] [Abstract][Full Text] [Related]
6. Ongoing risk of thrombosis with factor XI concentrate: 5 years experience in two centres.
Batty P; Honke A; Bowles L; Hart DP; Pasi KJ; Uprichard J; Austin SK
Haemophilia; 2015 Jul; 21(4):490-5. PubMed ID: 25855341
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of thrombin generation assay in factor XI deficiency.
Kasonga F; Feugray G; Chamouni P; Barbay V; Fresel M; Chretien MH; Brunel S; Le Cam Duchez V; Billoir P
Clin Chim Acta; 2021 Dec; 523():348-354. PubMed ID: 34670127
[TBL] [Abstract][Full Text] [Related]
8. Thrombin generation in patients with factor XI deficiency and clinical bleeding risk.
Rugeri L; Quélin F; Chatard B; De Mazancourt P; Negrier C; Dargaud Y
Haemophilia; 2010 Sep; 16(5):771-7. PubMed ID: 20398070
[TBL] [Abstract][Full Text] [Related]
9. Monitoring low dose recombinant factor VIIa therapy in patients with severe factor XI deficiency undergoing surgery.
Riddell A; Abdul-Kadir R; Pollard D; Tuddenham E; Gomez K
Thromb Haemost; 2011 Sep; 106(3):521-7. PubMed ID: 21833443
[TBL] [Abstract][Full Text] [Related]
10. Management of parturients with Factor XI deficiency-10year case series and review of literature.
Verghese L; Tingi E; Thachil J; Hay C; Byrd L
Eur J Obstet Gynecol Reprod Biol; 2017 Aug; 215():85-92. PubMed ID: 28622635
[TBL] [Abstract][Full Text] [Related]
11. Tissue Factor-Independent Coagulation Correlates with Clinical Phenotype in Factor XI Deficiency and Replacement Therapy.
Bertaggia Calderara D; Zermatten MG; Aliotta A; Batista Mesquita Sauvage AP; Carle V; Heinis C; Alberio L
Thromb Haemost; 2021 Feb; 121(2):150-163. PubMed ID: 32920807
[TBL] [Abstract][Full Text] [Related]
12. Sample conditions determine the ability of thrombin generation parameters to identify bleeding phenotype in FXI deficiency.
Pike GN; Cumming AM; Hay CR; Bolton-Maggs PH; Burthem J
Blood; 2015 Jul; 126(3):397-405. PubMed ID: 25911238
[TBL] [Abstract][Full Text] [Related]
13. Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency.
Zucker M; Seligsohn U; Salomon O; Wolberg AS
J Thromb Haemost; 2014 Jul; 12(7):1121-30. PubMed ID: 24815347
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of factor XI (FXI) concentrate use in patients with FXI deficiency: a single-centre experience of 19 years.
Ling G; Kagdi H; Subel B; Chowdary P; Gomez K
Haemophilia; 2016 May; 22(3):411-8. PubMed ID: 26663472
[TBL] [Abstract][Full Text] [Related]
15. Bleeding phenotype and correlation with factor XI (FXI) activity in congenital FXI deficiency: results of a retrospective study from a single centre.
Santoro C; Di Mauro R; Baldacci E; De Angelis F; Abbruzzese R; Barone F; Bochicchio RA; Ferrara G; Guarini A; Foà R; Mazzucconi MG
Haemophilia; 2015 Jul; 21(4):496-501. PubMed ID: 25623511
[TBL] [Abstract][Full Text] [Related]
16. How to Capture the Bleeding Phenotype in FXI-Deficient Patients.
Bertaggia Calderara D; Zermatten MG; Aliotta A; Alberio L
Hamostaseologie; 2020 Nov; 40(4):491-499. PubMed ID: 33003209
[TBL] [Abstract][Full Text] [Related]
17. Recombinant factor VIIa to prevent surgical bleeding in factor XI deficiency.
O'Connell NM; Riddell AF; Pascoe G; Perry DJ; Lee CA
Haemophilia; 2008 Jul; 14(4):775-81. PubMed ID: 18384352
[TBL] [Abstract][Full Text] [Related]
18. Report of surgeries, their outcome and the thrombin generation assay in patients with Factor XI deficiency: A retrospective single-centre study.
Désage S; Dargaud Y; Meunier S; Le Quellec S; Lienhart A; Negrier C; Nougier C; Rugeri L
Haemophilia; 2022 Mar; 28(2):301-307. PubMed ID: 35122661
[TBL] [Abstract][Full Text] [Related]
19. Tissue factor pathway inhibitor is a potential modifier of bleeding risk in factor XI deficiency.
Reitsma SE; Holle LA; Bouck EG; Monroe DM; Mast AE; Burthem J; Bolton-Maggs PHB; Gidley GN; Wolberg AS
J Thromb Haemost; 2023 Mar; 21(3):467-479. PubMed ID: 36696199
[TBL] [Abstract][Full Text] [Related]
20. The role of rotational thromboelastometry in assessment of haemostasis during pregnancy in women with factor XI deficiency.
Davies J; Harper A; Kadir RA
Haemophilia; 2016 Mar; 22(2):276-284. PubMed ID: 26538512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
